I agree, even though the brain scanner is point of focus at the moment, I'm pretty excited also by this liver opportunity boiling away in the background.
Interesting little article I found.
If these giant Pharma companies are developing drugs to treat this disease, i'm guessing they're probably going to want a device that can diagnose/screen a large population with out the need for biopsy in order to sell the drugs they've spent billions developing.
So i'll let people join the dots...
https://www.biospace.com/article/is-the-smoldering-nash-market-ready-to-burst-into-flames-/
Ann: Appendix 4C - quarterly, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.98 |
Change
0.020(1.02%) |
Mkt cap ! $174.4M | |||
| Open | High | Low | Value | Volume |
| $1.96 | $1.98 | $1.94 | $169.4K | 86.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 282 | $1.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.98 | 22897 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |
